Jin Y, Nonoyama S, Morio T, Imai K, Ochs H D, Mizutani S
Division of Human Ontogeny and Childhood Development, Graduate School, Tokyo Medical and Dental University, Japan.
J Med Dent Sci. 2001 Mar;48(1):23-7.
We report here that soluble CD40 ligand (sCD40L) is released from human platelets when activated with collagen or thrombin. The sCD40L was detectable in the culture supernatants of platelets within 30 min after stimulation in vitro, and reached maximal levels in 3 h. The release was blocked by the metalloproteinase inhibitor, KB8301, indicating that the soluble CD40L is made by cleaving the membrane bound CD40L expressed on activated platelets. The sCD40L was undetectable in the supernatant of the activated platelets obtained from patients with X-linked hyper IgM syndrome (XHIM), who have defects in CD40L gene. Since sCD40L has been shown to have biologic function on the activation of vascular endothelial cells and B cells, these findings suggest that platelets play some roles in both inflammation and humoral immune response by releasing soluble CD40L.
我们在此报告,当用胶原蛋白或凝血酶激活时,可溶性CD40配体(sCD40L)可从人血小板中释放出来。体外刺激后30分钟内,血小板培养上清液中可检测到sCD40L,并在3小时内达到最高水平。金属蛋白酶抑制剂KB8301可阻断这种释放,表明可溶性CD40L是通过切割活化血小板上表达的膜结合CD40L产生的。在X连锁高IgM综合征(XHIM)患者的活化血小板上清液中未检测到sCD40L,这些患者的CD40L基因存在缺陷。由于sCD40L已被证明对血管内皮细胞和B细胞的激活具有生物学功能,这些发现表明血小板通过释放可溶性CD40L在炎症和体液免疫反应中发挥某些作用。